apomorphine has been researched along with staurosporine aglycone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britto, LR; Chaves-Kirsten, GP; Ferreira, AF; Pires, RS; Real, CC; Torrão, AS | 1 |
| Joca, SRL; Pereira, VS; Suavinha, ACDR; Wegener, G | 1 |
2 other study(ies) available for apomorphine and staurosporine aglycone
| Article | Year |
|---|---|
BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Apomorphine; Carbazoles; Corpus Striatum; Disease Models, Animal; Enzyme Inhibitors; Exercise Test; Exercise Therapy; Gene Expression Regulation; Indole Alkaloids; Male; Oxidopamine; Parkinson Disease; Putamen; Rats; Rats, Wistar; Receptor, trkB; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Prelimbic neuronal nitric oxide synthase inhibition exerts antidepressant-like effects independently of BDNF signalling cascades.
Topics: Animals; Antidepressive Agents; Apomorphine; Brain-Derived Neurotrophic Factor; Carbazoles; Immobility Response, Tonic; Indazoles; Indole Alkaloids; Isoquinolines; Ketamine; Locomotion; Male; Microinjections; Nitric Oxide Synthase Type I; Ornithine; Prefrontal Cortex; Rats; Receptor, trkB; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2019 |